» Articles » PMID: 22674704

In Vitro and in Vivo Repeatability of Abdominal Diffusion-weighted MRI

Overview
Journal Br J Radiol
Specialty Radiology
Date 2012 Jun 8
PMID 22674704
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To study the in vitro and in vivo (abdomen) variability of apparent diffusion coefficient (ADC) measurements at 1.5 T using a free-breathing multislice diffusion-weighted (DW) MRI sequence.

Methods: DW MRI images were obtained using a multislice spin-echo echo-planar imaging sequence with b-values=0, 100, 200, 500, 750 and 1000 s mm(-2). A flood-field phantom was imaged at regular intervals over 100 days, and 10 times on the same day on 2 occasions. 10 healthy volunteers were imaged on two separate occasions. Mono-exponential ADC maps were fitted excluding b=0. Paired analysis was carried out on the liver, spleen, kidney and gallbladder using multiple regions of interest (ROIs) and volumes of interest (VOIs).

Results: The in vitro coefficient of variation was 1.3% over 100 days, and 0.5% and 1.0% for both the daily experiments. In vivo, there was no statistical difference in the group mean ADC value between visits for any organ. Using ROIs, the coefficient of reproducibility was 20.0% for the kidney, 21.0% for the gallbladder, 24.7% for the liver and 28.0% for the spleen. For VOIs, values fall to 7.7%, 6.4%, 8.6% and 9.6%, respectively.

Conclusion: Good in vitro repeatability of ADC measurements provided a sound basis for in vivo measurement. In vivo variability is higher and when considering single measurements in the abdomen as a whole, only changes in ADC value greater than 23.1% would be statistically significant using a two-dimensional ROI. This value is substantially lower (7.9%) if large three-dimensional VOIs are considered.

Citing Articles

The QIBA Profile for Diffusion-Weighted MRI: Apparent Diffusion Coefficient as a Quantitative Imaging Biomarker.

Boss M, Malyarenko D, Partridge S, Obuchowski N, Shukla-Dave A, Winfield J Radiology. 2024; 313(1):e233055.

PMID: 39377680 PMC: 11537247. DOI: 10.1148/radiol.233055.


Evaluating Reproducibility of the ADC and Distortion in Diffusion-weighted Imaging (DWI) with Reverse Encoding Distortion Correction (RDC).

Numamoto H, Fujimoto K, Miyake K, Fushimi Y, Okuchi S, Imai R Magn Reson Med Sci. 2023; 24(1):66-77.

PMID: 37952942 PMC: 11733504. DOI: 10.2463/mrms.mp.2023-0102.


A whole-body diffusion MRI normal atlas: development, evaluation and initial use.

Sjoholm T, Tarai S, Malmberg F, Strand R, Korenyushkin A, Enblad G Cancer Imaging. 2023; 23(1):87.

PMID: 37710346 PMC: 10503210. DOI: 10.1186/s40644-023-00603-5.


MRI Apparent Diffusion Coefficient (ADC) as a Biomarker of Tumour Response: Imaging-Pathology Correlation in Patients with Hepatic Metastases from Colorectal Cancer (EORTC 1423).

Jackson A, Pathak R, deSouza N, Liu Y, Jacobs B, Litiere S Cancers (Basel). 2023; 15(14).

PMID: 37509240 PMC: 10377224. DOI: 10.3390/cancers15143580.


Test-retest repeatability of ADC in prostate using the multi b-Value VERDICT acquisition.

Rogers H, Singh S, Barnes A, Obuchowski N, Margolis D, Malyarenko D Eur J Radiol. 2023; 162:110782.

PMID: 37004362 PMC: 10334409. DOI: 10.1016/j.ejrad.2023.110782.


References
1.
Koh D, Collins D . Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol. 2007; 188(6):1622-35. DOI: 10.2214/AJR.06.1403. View

2.
Chenevert T, Galban C, Ivancevic M, Rohrer S, Londy F, Kwee T . Diffusion coefficient measurement using a temperature-controlled fluid for quality control in multicenter studies. J Magn Reson Imaging. 2011; 34(4):983-7. PMC: 3177164. DOI: 10.1002/jmri.22363. View

3.
Messiou C, Collins D, Morgan V, deSouza N . Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility. Eur Radiol. 2011; 21(8):1713-8. DOI: 10.1007/s00330-011-2116-4. View

4.
Zhang J, Sigmund E, Chandarana H, Rusinek H, Chen Q, Vivier P . Variability of renal apparent diffusion coefficients: limitations of the monoexponential model for diffusion quantification. Radiology. 2010; 254(3):783-92. PMC: 2851010. DOI: 10.1148/radiol.09090891. View

5.
Koh D, Blackledge M, Collins D, Padhani A, Wallace T, Wilton B . Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial. Eur Radiol. 2009; 19(11):2728-38. DOI: 10.1007/s00330-009-1469-4. View